U.S. Clinical Nutrition Market to Surpass US$ 6,1 61.4 Million by 2027 - Coherent Market Insights

U.S. Clinical Nutrition Market, by Nutrition Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition) and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals, and Others)), by Form (Powder, Liquid, and Others), by Age Group (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, and Other Applications), and by End User (Hospitals, Ambulatory Surgical Centers, and Long Term Care Facilities), is estimated to be valued at US$ 4,148.9  million in 2020 and is expected to exhibit a CAGR of 5.8% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing prevalence of obesity, lifestyle diseases, and chronic diseases in the U.S. is expected to boost the clinical nutrition market growth. For instance, as per data provided by U.S. Department of Health and Human Services, it is estimated that 70.2% of the adult population in U.S considered to have obesity in 2016. Key players operating in the U.S. clinical nutrition market are focusing on development of technologically advanced nutrition products. For instance, in May 2019, Baxter International Inc. launched Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S

Clinical nutrition is indicated for various diseases such as diabetes, cancer, metabolic syndrome, inflammatory bowel movement (IBD), and others. Tablets, capsules, and powders are the most widely available forms of medical food in the U.S clinical nutrition market. Moreover, ready-to-drink (RTD) formulations are gaining significant traction. Other forms such as bars, wafers, and chewable forms are also gaining popularity among the U.S. populace. For instance, in 2019, Church & Dwight Co., Inc. has launched vitafusion brand (nutritional gummies) USDA-certified organic line of dietary supplements that includes Women’s Multi, Men’s Multi, Vitamin D3, and Vitamin B-12. The new products are also certified vegetarian by the America Vegetarian Association (AVA).

U.S. Clinical Nutrition Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID-19 pandemic.

Coronavirus pandemic has negatively impacted the development, production, and supply of nutritional products and affected growth of the nutrition and healthcare businesses of various companies across the globe, as COVID 19 pandemic has led to unprecedented lockdown in several countries, globally. This lockdown has resulted in closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the products. The COVID-19 pandemic has affected the economy in three main ways; 1) By directly affecting the production and demand; 2) By creating disruptions in distribution channels; and 3) By its financial impact on firms and financial markets. The impact of coronavirus (COVID-19) pandemic is expected to limit growth of the U.S clinical nutrition market during the forecast period

Factors such as investments in research and development of novel nutritional products targeting COVID-19, as well as funding by various companies operating in the nutrition sector are expected to drive the U.S. clinical nutrition market growth during the COVID-19 pandemic.

Major developments and launches of medical nutritional products targeting health conditions such as cancer, diabetes, and others, and collaborations among the major players are highly contributing to the market growth.   In April 2018, Abbott Nutrition, a nutrition division of Abbott Laboratories, introduced Ensure Max Protein, a 150 calorie nutrition drink with 30 grams of high-quality protein and 1 gram of sugar for adults. This new nutrition drink gives adults all the perks of protein, from maintaining or rebuilding muscle mass to helping satisfy hunger and it is an on-the-go option for a busy day.

Browse 18 Market Data Tables and 31 Figures spread through 154 Pages and in-depth TOC on “U.S. Clinical Nutrition Market”-  Forecast to 2027, by Nutrition Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition), and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals, and Others)), by Form (Powder, Liquid, and Others), by Age Group (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, and Other Applications), and by End User (Hospitals, Ambulatory Surgical Centers, and Long Term Care Facilities)

https://www.coherentmarketinsights.com/market-insight/us-clinical-nutrition-market-4412

Moreover, increasing prevalence of cancer in the U.S. is expected to drive the market growth over the forecast period. In September 2019, Nestlé Health Science, a subsidiary of Nestlé S.A., announced the global launch of BOOST Soothe clear nutritional drink, designed for cancer patients. This drink provides proteins and calories as well as a cooling, soothing effect to help patients get the nutrition they need while dealing with certain side effects of cancer treatment such as oral discomfort and taste changes.

Key Takeaways of the U.S. Clinical Nutrition Market:

• The U.S. Clinical Nutrition Market is expected to exhibit a CAGR of 5.8% during the forecast period, owing to the increasing investments by companies in research and development of novel medical nutritional products targeting various health conditions, as well as funding by various companies operating in nutrition industries For instance, in May 2020, Danone’s nutrition health arm, Nutricia, granted US$ 1.1 million for the U.S. nutrition research programme, a clinician-initiated research project in 16 countries including the U.S. and other countries to define guidelines for nutritional care for COVID-19 patients recovering after intensive care unit (ICU)
• Among nutrition type, enteral nutrition segment accounted for the largest market share in 2020, owing to increasing approval of novel products. In June 2020, Otsuka Pharmaceutical Factory Inc. launched its new ENORAS Liquid for enteral use in coffee flavor and strawberry flavor. It is indicated for nutritional support in postoperative patients.
• Increasing launches of novel powder form products by key players is expected to drive the Nutrition segment growth in the U.S. clinical nutrition market during the forecast period. For instance, in July 2019, Nestle Inc. globally launched Modulen IBD, a new powder nutrition-based medical food product, for the management of Crohn's disease
• Moreover, increasing launches of adult nutrition products is expected to drive the adult segment growth over the forecast period. For instance, in February 2018, Danone launched new Activia Dailies, a line of delicious, quick, and easy probiotic low fat yogurt drinks, to its robust portfolio of probiotic offerings. Activa Dailies product line offered by Danone S.A is available in various regions such as North America, Europe, and Asia Pacific.
• The increasing prevalence of diabetes is expected to drive demand for nutrition products for treatment of diabetes and segment growth during the forecast period. According to the American Diabetes Association report 2019, almost 210,000 Americans under age 20 are estimated to have diagnosed diabetes, which is around 0.25% of the U.S. population
• Major players operating in the U.S. clinical nutrition market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company LLC, and Perrigo Company PLC.